Disposition of 8727 shares by Steven Fruchtman of Onconova Therapeutics at 0.9 subject to Rule 16b-3

ONTXDelisted Stock  USD 1.02  0.04  3.77%   
Slightly above 62% of ONTX Old's investor base is looking to short. The analysis of current outlook of investing in ONTX Old suggests that many traders are alarmed regarding ONTX Old's prospects. ONTX Old's investing sentiment can be driven by a variety of factors including economic data, ONTX Old's earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Onconova Therapeutics Director, Officer: President, Chief Executive Off. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 8727 common stock at 0.9 of Onconova Therapeutics by Steven Fruchtman on 14th of March 2024. This event was filed by Onconova Therapeutics with SEC on 2024-03-14. Statement of changes in beneficial ownership - SEC Form 4. Steven Fruchtman currently serves as senior vice president - research and development, chief medical officer of Onconova Therapeutics

ONTX Old Fundamental Analysis

We analyze ONTX Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ONTX Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ONTX Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Number Of Employees

Number Of Employees Comparative Analysis

ONTX Old is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

ONTX Old Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ONTX Old stock to make a market-neutral strategy. Peer analysis of ONTX Old could also be used in its relative valuation, which is a method of valuing ONTX Old by comparing valuation metrics with similar companies.

Peers

ONTX Old Related Equities

TNXPTonix Pharmaceuticals   12.89   
0%
100.0%
IBIOIbio   1.35   
0%
10.0%
JAGXJaguar Animal   0.45   
0%
3.0%
PULMPulmatrix   0.39   
0%
3.0%
ADILAdial Pharmaceuticals     
1.0%
0%
BPTHBio Path   1.54   
11.0%
0%
MBRXMoleculin Biotech   1.95   
15.0%
0%
GOVXGeoVax Labs   2.05   
15.0%
0%
SONNSonnet Biotherapeutics   4.62   
35.0%
0%
PALIPalisade Bio   4.90   
38.0%
0%
OCGNOcugen   5.53   
42.0%
0%
VXRTVaxart   5.58   
43.0%
0%
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Consideration for investing in ONTX Stock

If you are still planning to invest in ONTX Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ONTX Old's history and understand the potential risks before investing.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments